Schroder Investment Management Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11M | Buy |
|
|||||
|
2025
Q2 | $8.13M | Buy |
|
|||||
|
2025
Q1 | $3.05M | Sell |
|
|||||
|
2024
Q4 | $5.01M | Sell |
|
|||||
|
2024
Q3 | $15.6M | Buy |
|
|||||
|
2024
Q2 | $14.5M | Sell |
|
|||||
|
2024
Q1 | $16.8M | Buy |
|
|||||
|
2023
Q4 | $2.84M | Buy |
|
|||||
|
2023
Q3 | $341K | Sell |
|
|||||
|
2023
Q2 | $7.13M | Buy |
|
|||||
|
2023
Q1 | $8.25M | Sell |
|
|||||
|
2022
Q4 | $9.06M | Buy |
|
|||||
|
2022
Q3 | $8.63M | Sell |
|
|||||
|
2022
Q2 | $9.72M | Buy |
|
|||||
|
2022
Q1 | $7.6M | Buy |
|
|||||
|
2021
Q4 | $6.67M | Buy |
|
|||||
|
2021
Q3 | $5.19M | Sell |
|
|||||
|
2021
Q2 | $5.94M | Buy |
|
|||||
|
2021
Q1 | $6.2M | Buy |
|
|||||
|
2020
Q4 | $6.12M | Sell |
|
|||||
|
2020
Q3 | $5.27M | Buy |
|
|||||
|
2020
Q2 | $4.74M | Buy |
|